Skip to content
MarketScale
‹ Back to IndustriesSciences

WEFTEC 2019: 3 Things to Check Out

WEFTEC 2019 Is Upon Us   The 92nd Annual Technical Exhibition and Conference is held Sept. 21 – 25, 2019 at McCormick Place in Chicago, Illinois. MarketScale will be at the show, and we compiled a list of 3 things that we think you should see at WEFTEC.   1. Scavenger Hunt   The WEFTEC…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Ben Thomas · InnovationTrade ShowWaterWater Treatment
Share
WEFTEC 2019: 3 Things to Check Out

Key takeaways

01

WEFTEC 2019 Is Upon Us   The 92nd Annual Technical Exhibition and Conference is held Sept.

02

21 – 25, 2019 at McCormick Place in Chicago, Illinois.

03

MarketScale will be at the show, and we compiled a list of 3 things that we think you should see at WEFTEC.

WEFTEC 2019 Is Upon Us

The 92nd Annual Technical Exhibition and Conference is held Sept. 21 – 25, 2019 at McCormick Place in Chicago, Illinois. MarketScale will be at the show, and we compiled a list of 3 things that we think you should see at WEFTEC.

1. Scavenger Hunt

The WEFTEC 2019 Scavenger Hunt begins officially Monday at 8:30 a.m. It will be active until Wednesday at 1:00 p.m., after which entries will not be accepted.

How to Play

Pick up your Scavenger Hunt play card at the Membership Booth to get started.

Collect stamps from all participating locations at WEFTEC. (Participants who don’t submit a fully stamped card by the conclusion of the game period are not eligible to win.)

Completed scavenger hunt cards will be put into a drawing for a prize. One winner will be selected each day. The prizes are

Monday: a $50 American Express gift card

Tuesday: JBL Flip 4 Bluetooth stereo

Wednesday: an Amazon Echo Show 5.

Winners will be announced in the WEF Membership booth located in the WEF Plaza South Hall at 3 p.m. each day.

2. Innovation Showcase

Innovation helps move the business-as-usual thinking forward into something better – more cost-effective, more efficient, more user-friendly. At the 8th Annual WEFTEC Innovation Showcase, WEF and its Innovation Partners, BlueTech Research and Imagine H2O, create a unique program for entrepreneurs, investors, customers, and regulators that puts the spotlight on water sector innovation and provides access to the leaders and the technologies making it all happen.

The Innovation Showcase embraces learning through exhibits, educational sessions, and networking events covering:

  • Innovation trends in the industrial and municipal markets
  • Financial innovation and investment opportunities
  • Piloting and partnering with new technology companies
  • Building the regulatory environment to support innovation
  • Using data to underpin industrial and municipal system upgrades

3. Beer Garden

The beers will be available for tasting on Monday and Tuesday from 12 to 4 p.m. and Wednesday from 11 a.m. to 3 p.m. The Beer Garden will be located at Booth 7751 in North Hall B.

Much of the beer served will be made with recycled water. (The sustainable beer will be supplemented with other beers from the convention center.) Sustainable beers will be brewed by

  • Unreconciled Brewing Chicago,
  • Clean Water Services Pure Water Brew,
  • CDM Smith
  • the Kentucky/Tennessee Water Environment Association, and
  • WEF’s own Patrick Dube.

*Some contributions to this article were made by the official WEFTEC website.

For the latest science news and updates, head to our industry page or follow us on Twitter @MarketScale!

About the author

Ben Thomas
Ben ThomasHead of Pro AV, MarketScale

Ben Thomas serves as Head of Pro AV at MarketScale, where he leads content and media strategy for the pro AV sector. With over 15 years of award-winning experience across large-scale events, network television, OTT platforms, and podcasting, he has guided major B2B brands including Intel, Sennheiser, Samsung, and Philips to billions of content interactions. He holds a B.A. in Mass Communications and is recognized for his expertise in podcast hosting, public speaking, marketing, and content strategy.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Sciences Insights

Biopharma's $300 Billion Problem Is Driving the Biggest M&A Cycle in a Decade

Biopharma's $300 Billion Problem Is Driving the Biggest M&A Cycle in a Decade

The pharmaceutical industry is facing a significant challenge as over $300 billion in branded pharmaceutical revenue is set to lose patent protection by 2030. This revenue gap is driving the largest merger and acquisition cycle seen in a decade, with companies seeking external growth through acquisitions. This shift is impacting the entire life sciences supply chain, prompting strategic changes across the industry.

  • 01Over $300 billion in pharmaceutical revenue is at risk due to patent expirations by 2030.
  • 02Big Pharma is engaging in an aggressive cycle of mergers and acquisitions.
  • 03The acquisitions are reshaping the life sciences supply chain.

Jun 29, 2026

Quotient Sciences launches Phase I study of what it calls the first AI-formulated drug in the clinic

Quotient Sciences launches Phase I study of what it calls the first AI-formulated drug in the clinic

Quotient Sciences has initiated a Phase I clinical study at its UK facility for an oral solid dose formulation designed using artificial intelligence — what the company believes is the first AI-formulated drug to reach human clinical evaluation. The study, cleared by the UK's Medicines and Healthcare products Regulatory Agency, will assess safety and pharmacokinetics in healthy volunteers. The program, which used Intrepid Labs' machine learning algorithm, signals a broader shift in how contract drug development organizations are integrating AI across formulation and clinical workflows.

  • 01Quotient Sciences initiated a Phase I study of an AI-designed oral solid dose formulation at its UK facility following MHRA approval — the first such case the company believes has been reported.
  • 02The formulation was developed using Intrepid Labs' advanced machine learning algorithm in combination with Quotient Sciences' Translational Pharmaceutics platform.
  • 03The milestone is part of a broader CRDMO strategy to embed AI-enabled approaches across formulation development and clinical workflows, with implications for the wider contract pharma sector.

Jun 17, 2026

Quotient Sciences launches Phase I trial of what it calls the first AI-formulated drug to reach the clinic

Quotient Sciences launches Phase I trial of what it calls the first AI-formulated drug to reach the clinic

Quotient Sciences has initiated a Phase I clinical study of an oral solid dose formulation designed using AI, cleared by the UK's MHRA and conducted at the company's UK facility. The trial—built on machine learning algorithms from partner Intrepid Labs and Quotient's Translational Pharmaceutics platform—aims to validate AI as a direct contributor to formulation design rather than just an upstream analytical tool. Benchling characterizes the broader moment as biotech entering a "builder phase," in which leading organizations embed AI capability at the bench level rather than running isolated pilots.

  • 01Quotient Sciences has dosed healthy volunteers in a Phase I study it describes as the first clinical evaluation of an AI-designed oral formulation, following approval from the UK's MHRA.
  • 02The formulation was developed using advanced machine learning algorithms from Intrepid Labs, integrated with Quotient Sciences' Translational Pharmaceutics platform.
  • 03Benchling identifies a sector-wide shift toward embedding AI capability directly at the bench, moving beyond isolated pilots to structural adoption across biotech R&D.

Jun 17, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

Ben Thomas
Ben Thomas

Head of Pro AV

MarketScale

Ben Thomas serves as Head of Pro AV at MarketScale, where he leads content and media strategy for the pro AV sector. With over 15 years of award-winning experience across large-scale events, network television, OTT platforms, and podcasting, he has guided major B2B brands including Intel, Sennheiser, Samsung, and Philips to billions of content interactions. He holds a B.A. in Mass Communications and is recognized for his expertise in podcast hosting, public speaking, marketing, and content strategy.

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512